Jeffrey Cramblett, DPM
Foot & Ankle Surgery · Brownstown Twp, MINPI 1104039189
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (48.2%), food and beverage and education — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Pinnacle, Inc at 32.1% of the total. Reporting peaked in 2022 at $5,813 and has fallen 94.2% since, to $336 in 2025.
Across 110 payments — averaging $126.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pinnacle, Inc$4K
- Paragon 28, Inc.$3K
- Anika Therapeutics, Inc.$2K
- Arthrex$1K
- Stryker$1K
- Treace Medical Concepts, Inc.$811
- plus $1K from 13 others
What the payments were for
- Travel & lodging$6,69148%
- Food & beverage$3,58826%
- Education$3,51425%
- Gifts$931%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pinnacle, Inc | 18 | $4,452 |
| Paragon 28, Inc. | 16 | $3,203 |
| Anika Therapeutics, Inc. | 6 | $1,787 |
| Arthrex | 16 | $1,233 |
| Stryker(2 entities) | 17 | $1,079 |
| Treace Medical Concepts, Inc. | 3 | $811 |
| Johnson & Johnson | 9 | $464 |
| Osteomed LLC | 5 | $363 |
| Integra Lifesciences Corporation | 2 | $179 |
| Smith+Nephew | 4 | $74 |
| Orthofix Medical, Inc. | 6 | $66 |
| Organogenesis Inc. | 1 | $34 |
| Acumed LLC | 1 | $24 |
| Mimedx Group, Inc. | 1 | $23 |
| Abbott | 1 | $21 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $20 |
| Sebela Pharmaceuticals Inc. | 1 | $19 |
| Baxter Healthcare | 1 | $18 |
| Amgen | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HemiCAP$1,712
- Product Portfolio$1,631
- Lapiplasty System$811
- PROstep$516
- INTEGRA$380
- N/A$150
- VARIAX$145
- INTEGRA DERMAL REGENERATION TEMPLATE$127
- PRIMATRIX$127
- MINIBUNION$118
- EXT-Extremilock Foot$114
- AUGMENT INJECTABLE$109
How this compares
$13,887 in reported general payments places this provider in the 85th percentile of 384 foot & ankle surgery providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 78 | $3,834 |
| Fluconazole | 33 | $1,131 |
| Gabapentin | 36 | $665 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 19 | $283 |
| Mupirocin | 36 | $234 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 13 | $221 |
| Ketoconazole | 17 | $200 |
| Colchicine | 11 | $96 |
| Methylprednisolone | 12 | $49 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Brownstown Twp
- John AndersonGrand Rapids$1.3M
- Brian LoderClinton Township$854K
- Karl DunnClinton Twp$434K
- Anthony LalamaMacomb$421K
- Christopher ZingasSaint Clair Shores$227K
- John MaskillGrand Rapids$202K
- Michael SwordsLansing$189K
- Gregory SheremetaTroy$87K
- Jason WesloskyClinton Township$87K
- Hatim BurhaniGrosse Pointe Woods$77K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.